The findings of the second country-wide serological survey, conducted by the Indian Council of Medical Research (ICMR), were announced on 29 September. The survey was carried out from 17 August to 22 September in the same 700 villages or wards…

Live Discussion on Itolizumab and Coronavirus – COVID-19 Treatment | COVID-19 India There was big news out of India when the Drug Controller General of India (DCGI), approved the drug Itolizumab for emergency use for the treatment of cytokine release…

An update on the outcomes of the first phase of The PRESENCE Foundation India’s Immunity Boost Against Covid-19 (IBAC) program. The IBAC program was developed through the inspirations of Aaryaa Maharishikaa Preeti Maiyaa, a powerful modern-day female spiritual master in…